Re-treatment of patients with anti-HBe-positive chronic hepatitis B who relapsed after an initial course of lamivudine

This publication has 17 references indexed in Scilit:

• Interferon α Treatment and Retreatment of Hepatitis B e Antigen-Negative Chronic Hepatitis B
  Gastroenterology, 2001
• Management of hepatitis B: 2000—Summary of a workshop
  Gastroenterology, 2001
• Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B
  Gastroenterology, 2000
• Response of pre-core mutant chronic hepatitis B infection to lamivudine
  Journal of Medical Virology, 2000
• Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine
  Journal of Hepatology, 2000
• Efficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Bb
  Hepatology, 1999
• A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum
  Hepatology, 1997
• A Randomized Controlled Trial of Lymphoblastoid Interferon–α in Patients With Chronic Hepatitis B Lacking Hbeag
  Hepatology, 1992
• Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon
  Journal of Hepatology, 1992
• Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B
  Journal of Hepatology, 1990